Differential Effects of Cytochalasin B on Platelet Release, Aggregation and Contractility: Evidence against a Contractile Mechanism for the Release of Platelet Granular Contents

Summary

Cytochalasin B alters the structure and functional properties of filamentous actin. Platelet-mediated clot retraction in dilute platelet-rich plasma (PRP) is inhibited progressively at cytochalasin B concentrations of 0.01 mg/ml, 0.05 mg/ml and 0.1 mg/ml. Dynamic rheological measurements of recalcified PRP in a Weissenberg Rheogoniometer indicate that platelet contractility (as reflected in measurements of elastic moduli) is reduced by 33%, 57% and 63% at cytochalasin B concentrations of 0.01, 0.05 and 0.1 mg/ml, respectively.

In contrast, pre-incubation of human platelet-rich plasma (PRP) with 0.01 mg/ml or 0.05 mg/ml cytochalasin B does not inhibit collagen-induced [¹⁴C-]serotonin release or collagen-induced-platelet aggregation, which is dependent on the release of ADP from platelet dense granules. Even at a cytochalasin B concentration of 0.1 mg/ml, collagen-induced [¹⁴C-]serotonin release and aggregation are impaired only moderately. Cytochalasin B does not interfere with the uptake by platelets of [¹⁴C-]-serotonin, or with the kinetics and extent of clot formation in platelet-free plasma.

Thus, concentrations of cytochalasin B which impair platelet contractility do not inhibit the release of platelet dense granule contents. It is concluded that neither the platelet release reaction nor platelet aggregation is dependent on platelet contractile mechanisms.

• References

• 1 Abramowttz J, Malik MN, Stracher A, Detwiler TC. 1972; Studies on the contractile proteins from blood platelets. Cold Spring Harbor Symposia on Quantitative Biology 37: 595
• 2 Bettex-Galland M, Luscher EF. 1961; Thrombosthenin - a contractile protein from thrombocytes. Its extraction from human blood platelets and some of its properties Biochemica Biophysica Acta 49: 536
• 3 Cazzenave JP, Packham MA, Cuccione MA, Mustard JF. 1974; Inhibition of platelet adherence to a collagen-coated surface by agents that inhibit platelet shape change and clot retraction. Journal of Laboratory and Clinical Medicine 84: 483
• 4 Clarke M, Spudich J. 1977; Nonmuscle contractile proteins: The role of actin and myosin in cell motility and shape determination. Annual Review of Biochemistry 46: 797
• 5 Ferry JD. 1970. Viscoelastic Properties of Polymers. John Wiley and Sons; New York:
• 6 Glover CJ, Mcintire LV, Brown CH, Natelson EA. 1975; a Dynamic coagulation studies: influence of normal and abnormal platelets on clot structure formation. Thrombosis Research 7: 185
• 7 Glover CJ, McIntire LV, Brown CH, Natelson EA. 1975; b Rheological properties of fibrin clots. Effects of fibrinogen concentration, factor XIII deficiency, and factor XIII inhibition. Journal of Laboratory and Clinical Medicine 86: 644
• 8 Hartwig JH, Stossel TP. 1976; Interaction of actin myosin and actin binding protein of rabbit pulmonary macrophages III. Effect of cytochalasin B. Journal Cell Biology 71: 295
• 9 Haslam RM. 1972; Inhibition of blood platelet function by cytochalasins: effects on thrombosthe- nin and on glucose metabolism. Biochemical Journal 127: 34
• 10 Haslam RJ, Davidson MM L, Mcclenaghan MD. 1975; Cytochalasin B, the blood platelet release reaction and cyclic GMP. Nature 253: 455
• 11 Hoffstein S, Weissman G. 1978; Microfilaments and microtubules in calcium ionophore- induced secretion of lysosomal enzymes from human polymorphonuclear leukocytes. Journal of Cell Biology 78: 769
• 12 Niewiarowski S, Regoeczi E, Stewart G, Senyi A, Mustard JF. 1972; Platelet interaction with polymerizing fibrin. Journal of Clinical Investigation 51: 685
• 13 Shepro DF, Belamarich FA, Robblee L, Chao FC. 1970; Antimotility effect of cytochalasin B observed in mammalian clot retraction. Journal of Cell Biology 47: 544
• 14 Spudich JA, Lin S. 1972; Cytochalasin B, its interaction with actin and actomyosin from smooth muscle. Proceeedings of the National Academy of Science (U.S.A.) 69: 442
• 15 Spudich JA. 1973; Effects of cytochalasin B on actin filaments. Cold Spring Harbor Symposia on Quantitative Biology 37: 585
• 16 Weihring RR. 1976; Cytochalasin B inhibits actin-related gelation of Hela Cell extracts. Journal of Cell Biology 71: 303
• 17 Weiss HJ, Tschopp TB, Rogers J, Brand H. 1974; Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease. Journal of Clinical Investigation 54: 421
• 18 Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, Wrenn JT, Yamada KM. 1971; Microfilaments in cellular and developmental processes. Science 171: 135
• 19 White JG. 1971. Platelet microtubles and microfilaments: effects of cytochalasin B on structure and function. In: Caen J. (ed.) Platelet Aggregation. Maison et Cie; Paris: p 15
• 20 Widmer K, Moake JL. 1976; Clot retraction: evaluation in dilute suspensions of platelet-rich plasma and gel-separated platelets. Journal of Laboratory and Clinical Medicine 87: 49
• 21 Zucker-Franklin D, Nachman RL, Marcus AJ. 1967; Ultrastructure of thrombosthenin, the contractile protein of human blood platelets. Science 157: 945
• 22 Zucker-Franklin D, Bloomberg N. 1969; Microfibrils of blood platelets: their relationship to microtubules and the contractile protein. Journal of Clinical Investigation 48: 165
• 23 Zurier RB, Hoffstein S, Weissman G. 1973; Cytochalasin B: effect on lysosomal enzyme release from human leukocytes. Proceedings of the National Academy of Science (U.S.A.) 70: 844